Skip to content

Acceptance Of A Partially-Hydrolyzed Infant Formula

Acceptance Of A Partially-Hydrolyzed Infant Formula

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03223792
Enrollment
100
Registered
2017-07-21
Start date
2017-08-21
Completion date
2018-12-31
Last updated
2019-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stool

Brief summary

This clinical trial will evaluate stool consistency in infants receiving one of two study formulas through a 14-day feeding period.

Interventions

OTHERControl

Routine cow's milk-based infant formula

Partially-hydrolyzed cow's milk protein infant formula

Sponsors

Mead Johnson Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
28 Days to 300 Days
Healthy volunteers
Yes

Inclusion criteria

* Singleton 28-300 days of age at randomization * Gestational age less than or equal to 35 weeks * Receiving minimum 18oz infant formula in the 24hrs prior to randomization * History of hard stools or stooling difficulty * Signed informed consent and protected health information

Exclusion criteria

* Current diagnosis of cow's milk protein allergy or intolerance * Use of extensively hydrolyzed or amino acid formula at randomization * Any abdominal or gastrointestinal surgery prior to randomization * History of underlying metabolic or chronic disease or congenital malformation * Organic causes of constipation

Design outcomes

Primary

MeasureTime frame
Stool consistency measured by MJN stool consistency scale14 days

Secondary

MeasureTime frame
Stool frequency14 days
Formula acceptance measured by intake diary14 days
Formula gastrointestinal tolerance measured by diary14 days
Bowel movement characteristics by diary14 days
Medically confirmed adverse events throughout the study period14 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026